Inhaled corticosteroids in children: Effects on bone mineral density and growth

The Lancet Respiratory Medicine

Volumn 2, Issue 6, 2014, Pages 487-496

  Fuhlbrigge, Anne L ^a   Kelly, H William ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; MOMETASONE FUROATE; NEDOCROMIL; PLACEBO; SALMETEROL; THEOPHYLLINE; TRIAMCINOLONE ACETONIDE;

ALLERGIC RHINITIS; ALLERGY; ASTHMA; BODY HEIGHT; BONE DENSITY; BONE MASS; BONE MATURATION; CATCH UP GROWTH; CHILD; DISEASE EXACERBATION; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG DOSE COMPARISON; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; DRUG SAFETY; DRY POWDER INHALER; EVENING DOSAGE; FACE MASK; FRACTURE; GROWTH; GROWTH ACCELERATION; GROWTH DISORDER; GROWTH RATE; HUMAN; LOW DRUG DOSE; METERED DOSE INHALER; MILD PERSISTENT ASTHMA; MODERATE PERSISTENT ASTHMA; MORNING DOSAGE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; PUBERTY; RECOMMENDED DRUG DOSE; REVIEW; SEVERE PERSISTENT ASTHMA; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN; CHILD DEVELOPMENT; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ASTHMA; BONE DENSITY; CHILD; CHILD DEVELOPMENT; HUMANS;

EID: 84901820988     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(14)70024-4     Document Type: Review

References (77)

1. Kelly HW, Nelson HS Potential adverse effects of the inhaled corticosteroids. J Allergy Clin Immunol 2003, 112:469-478.
2. Pedersen S Clinical safety of inhaled corticosteroids for asthma in children: an update of long-term trials. Drug Saf 2006, 29:599-612.
3. Tinkelman DG, Reed CE, Nelson HS, Offord KP Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993, 92:64-77.
4. Wolthers OD Long-, intermediate- and short-term growth studies in asthmatic children treated with inhaled glucocorticosteroids. Eur Respir J 1996, 9:821-827.
5. Orally inhaled and intranasal corticosteroids: evaluation of the effects on growth in children US Department of Health and Human Services Food, Drug Administration Center for Drug Evaluation and Research, Guidance for industryGuidance for industry, (accessed March 8, 2014). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071968.pdf.
6. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000, 343:1054-1063. The Childhood Asthma Management Program Research Group.
7. Sharek PJ, Bergman DA The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis. Pediatrics 2000, 106:E8.
8. Verberne AA, Frost C, Roorda RJ, van der Laag H, Kerrebijn KF One year treatment with salmeterol compared with beclomethasone in children with asthma. Am J Respir Crit Care Med 1997, 156:688-695. the Dutch Paediatric Asthma Study Group.
9. Pauwels RA, Pedersen S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 2003, 361:1071-1076. the START Investigators Group.
10. Van Bever HP, Desager KN, Lijssens N, Weyler JJ, Du Caju MVL Does treatment of asthmatic children with inhaled corticosteroids affect their adult height?. Pediatr Pulmonol 1999, 27:369-375.
11. Silverstein MD, Yunginger JW, Reed CE, et al. Attained adult height after childhood asthma: effect of glucocorticoid therapy. J Allergy Clin Immunol 1997, 99:466-474.
12. Inoue T, Doi S, Takamatsu I, Murayama N, Kameda M, Toyoshima K Effect of long-term treatment with inhaled beclomethasone dipropionate on growth of asthmatic children. J Asthma 1999, 36:159-164.
13. Larsson L, Gerhardsson de Verdier M, Lindmark B, Norjavaara E Budesonide-treated asthmatic adolescents attain target height: a population-based follow-up study from Sweden. Pharmacoepidemiol Drug Saf 2002, 11:715-720.
14. Norjavaara E, Gerhardsson De Verdier M, Lindmark B Reduced height in Swedish men with asthma at the age of conscription for military service. J Pediatr 2000, 137:25-29.
15. Agertoft L, Pedersen S Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000, 343:1064-1069.
16. Expert Panel Report 3 (EPR3): guidelines for the diagnosis and management of asthma 2007, National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD, (accessed March 8, 2014). http://www.nhlbi.nih.gov/guidelines/asthma.
17. Strunk RC, Sternberg AL, Szefler SJ, Zeiger RS, Bender B, Tonascia J Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents. J Pediatr 2009, 154:682-687. the Childhood Asthma Management Program (CAMP) Research Group.
18. Kelly HW, Sternberg AL, Lescher R, et al. Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med 2012, 367:904-912. the CAMP Research Group.
19. Kelly HW Comparison of inhaled corticosteroids: an update. Ann Pharmacother 2009, 43:519-527.
20. Derendorf H, Nave R, Drollmann A, Cerasoli F, Wurst W Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Eur Respir J 2006, 28:1042-1050.
21. Rossi GA, Cerasoli F, Cazzola M Safety of inhaled corticosteroids: room for improvement. Pulm Pharmacol Ther 2007, 20:23-35.
22. Allen DB Systemic effects of intranasal steroids: an endocrinologist's perspective. J Allergy Clin Immunol 2000, 106(suppl):S179-S190.
23. Ferguson AC, Spier S, Manjra A, Versteegh FGA, Mark S, Zhang P Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide. J Pediatr 1999, 134:422-427.
24. Ferguson AC, Van Bever HP, Teper AM, Lasytsya O, Goldfrad CH, Whitehead PJ A comparison of the relative growth velocities with budesonide and fluticasone propionate in children with asthma. Respir Med 2007, 101:118-129.
25. Acun C, Tomac N, Ermis B, Onk G Effects of inhaled corticosteroids on growth in asthmatic children: a comparison of fluticasone propionate with budesonide. Allergy Asthma Proc 2005, 26:204-206.
26. de Benedictis FM, Teper A, Green RJ, Boner AL, Williams L, Medley H Effects of 2 inhaled corticosteroids on growth: results of a randomized controlled trial. Arch Pediatr Adolesc Med 2001, 155:1248-1254. the International Study Group.
27. Martin RJ, Szefler SJ, Chinchilli VM, et al. Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med 2002, 165:1377-1383.
28. Allen DB, Bronsky EA, LaForce CF, et al. Growth in asthmatic children treated with fluticasone propionate. J Pediatr 1998, 132:472-477. the Fluticasone propionate Asthma Study Group.
29. Skoner DP, Meltzer EO, Milgrom H, Stryszak P, Teper A, Staudinger H Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma. J Asthma 2011, 48:848-859.
30. Martinez FD, Chinchilli VM, Morgan WJ, et al. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. Lancet 2011, 377:650-657.
31. Skoner DP, Rachelefsky GS, Meltzer EO, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000, 105:E23.
32. Schenkel EJ, Skoner DP, Bronsky EA, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 2000, 105:E22.
33. Nasacort AQ nasal spray FDA advisory committee briefing document. Briefing Information for the July 31, 2013 Meeting of the Nonprescription Drug Advisory Committee (NDAC) Sanofi-Aventis, (accessed Aug 24, 2013). http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/NonprescriptionDrugsAdvisoryCommittee/ucm362808.htm.
34. Veramyst prescribing information GlaxoSmithKline, (accessed Aug 24, 2013). http://us.gsk.com/products/assets/us_veramyst.pdf.
35. Skoner DP, Maspero J, Banerji D Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics 2008, 121:e1-14. the Ciclesonide Pediatric Growth Study Group.
36. Ruge CA, Kirch J, Lehr C-M Pulmonary drug delivery: from generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challenges. Lancet Respir Med 2013, 1:402-413.
37. Visser MJ, van der Veer E, Postma DS, et al. Side-effects of fluticasone in asthmatic children: no effects after dose reduction. Eur Respir J 2004, 24:420-425.
38. Doull IJ, Freezer NJ, Holgate ST Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med 1995, 151:1715-1719.
39. Allen DB Inhaled corticosteroid therapy for asthma in preschool children: growth issues. Pediatrics 2002, 109(suppl):373-380.
40. Merkus PJ, van Essen-Zandvliet EE, Duiverman EJ, van Houwelingen HC, Kerrebijn KF, Quanjer PH Long-term effect of inhaled corticosteroids on growth rate in adolescents with asthma. Pediatrics 1993, 91:1121-1126.
41. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006, 354:1985-1997.
42. Guilbert TW, Mauger DT, Allen DB, et al. Growth of preschool children at high risk for asthma 2 years after discontinuation of fluticasone. J Allergy Clin Immunol 2011, 128:956-963. the Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute, e1-7.
43. Bisgaard H, Gillies J, Groenewald M, Maden C The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study. Am J Respir Crit Care Med 1999, 160:126-131.
44. Bisgaard H, Allen D, Milanowski J, Kalev I, Willits L, Davies P Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics 2004, 113:e87-e94.
45. Blake K, Mehta R, Spencer T, Kunka RL, Hendeles L Bioavailability of inhaled fluticasone propionate via chambers/masks in young children. Eur Respir J 2012, 39:97-103.
46. Elmallah MK, Khan Y, Hochhaus G, Shuster JJ, Hendeles L Systemic exposure to fluticasone MDI delivered through antistatic chambers. J Allergy Clin Immunol 2011, 128:1113-1115. e1-3.
47. Ducharme FM, Lemire C, Noya FJ, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med 2009, 360:339-353.
48. Zeiger RS, Mauger D, Bacharier LB, et al. Daily or intermittent budesonide in preschool children with recurrent wheezing. N Engl J Med 2011, 365:1990-2001. the CARE Network of the National Heart, Lung, and Blood Institute.
49. Louca E, Leung K, Coates AL, Mitchell JP, Nagel MW Comparison of three valved holding chambers for the delivery of fluticasone propionate-HFA to an infant face model. J Aerosol Med 2006, 19:160-167.
50. Russell G Childhood asthma and growth-a review of the literature. Respir Med 1994, 88(suppl A):31-36.
51. Snyder RD, Collipp PJ, Greene JS Growth and ultimate height of children with asthma. Clin Pediatr 1967, 6:389-392.
52. Patel L, Clayton PE, Addison GM, Price DA, David TJ Linear growth in prepubertal children with atopic dermatitis. Arch Dis Child 1998, 79:169-172.
53. Ferguson AC, Murray AB, Tze W-J Short stature and delayed skeletal maturation in children with allergic disease. J Allergy Clin Immunol 1982, 69:461-466.
54. Mortimer KJ, Harrison TW, Tattersfield AE Effects of inhaled corticosteroids on bone. Ann Allergy Asthma Immunol 2005, 94:15-21.
55. Seibel MJ, Cooper MS, Zhou H Glucocorticoid-induced osteoporosis: mechanisms, management and future perspectives. Lancet Diabetes Endocrinol 2013, 1:59-70.
56. Buehring B, Viswanathan R, Binkley N, Busse W Glucocorticoid-induced osteoporosis: an update on effects and management. J Allergy Clin Immunol 2013, 132:1019-1030.
57. van Staa TP, Cooper C, Leufkens HG, Bishop N Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res 2003, 18:913-918.
58. Harris M, Hauser S, Nguyen TV, et al. Bone mineral density in prepubertal asthmatics receiving corticosteroid treatment. J Paediatr Child Health 2001, 37:67-71.
59. Jones G, Ponsonby AL, Smith BJ, Carmichael A Asthma, inhaled corticosteroid use, and bone mass in prepubertal children. J Asthma 2000, 37:603-611.
60. Agertoft L, Pedersen S Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide. Am J Respir Crit Care Med 1998, 157:178-183.
61. Bahceciler NN, Sezgin G, Nursoy MA, Barlan IB, Basaran MM Inhaled corticosteroids and bone density of children with asthma. J Asthma 2002, 39:151-157.
62. Griffiths AL, Sim D, Strauss B, Rodda C, Armstrong D, Freezer N Effect of high-dose fluticasone propionate on bone density and metabolism in children with asthma. Pediatr Pulmonol 2004, 37:116-121.
63. Baraldi E, Bollini MC, De Marchi A, Zacchello F Effect of beclomethasone dipropionate on bone mineral content assessed by X-ray densitometry in asthmatic children: a longitudinal evaluation. Eur Respir J 1994, 7:710-714.
64. Martinati LC, Bertoldo F, Gasperi E, Fortunati P, Lo Cascio V, Boner AL Longitudinal evaluation of bone mass in asthmatic children treated with inhaled beclomethasone dipropionate or cromolyn sodium. Allergy 1998, 53:705-708.
65. Roux C, Kolta S, Desfougères J-L, Minini P, Bidat E Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma. Pediatrics 2003, 111:e706-e713.
66. Kelly HW, Van Natta ML, Covar RA, Tonascia J, Green RP, Strunk RC Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study. Pediatrics 2008, 122:e53-e61. the CAMP Research Group.
67. Tse SM, Kelly HW, Litonjua AA, Van Natta ML, Weiss ST, Tantisira KG Corticosteroid use and bone mineral accretion in children with asthma: effect modification by vitamin D. J Allergy Clin Immunol 2012, 130:53-60. the Childhood Asthma Management Program Research Group, e4.
68. Turpeinen M, Pelkonen AS, Nikander K, et al. Bone mineral density in children treated with daily or periodical inhaled budesonide: the Helsinki Early Intervention Childhood Asthma study. Pediatr Res 2010, 68:169-173.
69. Gafni RI, Baron J Childhood bone mass acquisition and peak bone mass may not be important determinants of bone mass in late adulthood. Pediatrics 2007, 119(suppl 2):S131-S136.
70. Agertoft L, Pedersen S Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994, 88:373-381.
71. Ninan TK, Russell G Asthma, inhaled corticosteroid treatment, and growth. Arch Dis Child 1992, 67:703-705.
72. Russel G, Ninan T, Carter PR, Smail I, Smail P Effects of inhaled corticosteroids on HPA function and growth in children. Res Clin Forums 1989, 3:77-86.
73. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma. Summary report 2007. J Allergy Clin Immunol 2007, 120(5 suppl):S94-138. NAEPP.
74. Caudri D, Wijga AH, Smit HA, et al. Asthma symptoms and medication in the PIAMA birth cohort: evidence for under and overtreatment. Pediatr Allergy Immunol 2011, 22:652-659.
75. Kraft M, Israel E, O'Connor GT Clinical Decisions: treatment of mild persistent asthma. [clinical vignette]. N Engl J Med 2007, 356:2096-2100.
76. Chauhan BF, Chartrand C, Ducharme FM Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. Cochrane Database Syst Rev 2013, 2. CD009611.
77. Maspero J, Backer V, Yao R, Staudinger H, Teper A Effects of mometasone, fluticasone, and montelukast on bone mineral density in adults with asthma. J Allergy Clin Immunol Pract 2013, 1:649-655.